ATE420366T1 - ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN - Google Patents

ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN

Info

Publication number
ATE420366T1
ATE420366T1 AT01995216T AT01995216T ATE420366T1 AT E420366 T1 ATE420366 T1 AT E420366T1 AT 01995216 T AT01995216 T AT 01995216T AT 01995216 T AT01995216 T AT 01995216T AT E420366 T1 ATE420366 T1 AT E420366T1
Authority
AT
Austria
Prior art keywords
ßtethering
advanced
approach
quickly
finding ligands
Prior art date
Application number
AT01995216T
Other languages
English (en)
Inventor
Daniel Erlanson
Andrew Braisted
Robert Mcdowell
John Prescott
Original Assignee
Sunesis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sunesis Pharmaceuticals Inc filed Critical Sunesis Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE420366T1 publication Critical patent/ATE420366T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B50/00Methods of creating libraries, e.g. combinatorial synthesis
    • C40B50/14Solid phase synthesis, i.e. wherein one or more library building blocks are bound to a solid support during library creation; Particular methods of cleavage from the solid support
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718Type of compounds synthesised
    • B01J2219/0072Organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11Compounds covalently bound to a solid support
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Structural Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Control And Safety Of Cranes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Adhesives Or Adhesive Processes (AREA)
AT01995216T 2000-11-21 2001-11-20 ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN ATE420366T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25229400P 2000-11-21 2000-11-21

Publications (1)

Publication Number Publication Date
ATE420366T1 true ATE420366T1 (de) 2009-01-15

Family

ID=22955415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01995216T ATE420366T1 (de) 2000-11-21 2001-11-20 ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN

Country Status (14)

Country Link
EP (2) EP1441228B1 (de)
JP (2) JP3836791B2 (de)
AT (1) ATE420366T1 (de)
AU (2) AU2002225731B2 (de)
CA (1) CA2430234C (de)
DE (1) DE60137356D1 (de)
DK (1) DK1337853T3 (de)
ES (1) ES2322796T3 (de)
HK (1) HK1063844A1 (de)
IL (2) IL155926A0 (de)
MX (1) MXPA03004435A (de)
NZ (1) NZ525861A (de)
WO (1) WO2002042773A2 (de)
ZA (1) ZA200303772B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214487B2 (en) * 1998-06-26 2007-05-08 Sunesis Pharmaceuticals, Inc. Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
US6998233B2 (en) 1998-06-26 2006-02-14 Sunesis Pharmaceuticals, Inc. Methods for ligand discovery
EP1421063A1 (de) * 2001-08-07 2004-05-26 Sunesis Pharmaceuticals, Inc. Disulfid- und thiosulfonatliganden, und bibliotheken, die diese liganden umfassen
EP1446496A4 (de) * 2001-11-21 2005-03-30 Sunesis Pharmaceuticals Inc Verfahren für die entdeckung von liganden
US7202033B2 (en) 2002-03-21 2007-04-10 Sunesis Pharmaceuticals, Inc. Identification of kinase inhibitors
EP2581849A1 (de) 2002-07-24 2013-04-17 Keddem Bio-Science Ltd. Arzneimittelentwicklungsverfahren
EP1576375B1 (de) 2002-12-23 2007-02-14 Astex Therapeutics Limited Synthese und screening von liganden mit hilfe von röntgenkristallographie
CA2539064A1 (en) * 2003-09-17 2005-04-21 Sunesis Pharmaceuticals, Inc. Identification of kinase inhibitors
EP1682525B1 (de) * 2003-11-14 2013-12-25 3M Innovative Properties Company N-sulfonylaminocarbonylhaltige verbindungem
WO2005101019A2 (en) * 2004-04-12 2005-10-27 University Of Vermont And State Agricultural College Detection of nitrosylated proteins
CA2587424A1 (en) * 2004-11-16 2006-05-26 Avidia Research Institute Protein scaffolds and uses thereof
US20080070802A1 (en) * 2006-08-23 2008-03-20 Moerschell Richard P Directed heterobifunctional linkers
US8859731B2 (en) 2010-04-21 2014-10-14 Novo Nordisk A/S Selective modification of proteins
MX2012015293A (es) 2010-07-02 2013-05-30 Gilead Sciences Inc Derivados de acido 2-quinolinil-acetico como compuestos antivirales.
BR112013000043A2 (pt) 2010-07-02 2019-09-24 Gilead Sciences Inc derivados de ácido naft-2-ilacético para tratar aids
ES2707997T3 (es) 2011-04-21 2019-04-08 Gilead Sciences Inc Compuestos de benzotiazol y su uso farmacéutico
WO2013103738A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. Napthalene acetic acid derivatives against hiv infection
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
ES2571479T3 (es) 2012-04-20 2016-05-25 Gilead Sciences Inc Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH
WO2015023724A1 (en) * 2013-08-13 2015-02-19 The Scripps Research Institute Cysteine-reactive ligand discovery in proteomes
EP3100731A4 (de) * 2014-01-29 2017-12-20 Shanghai Hengrui Pharmaceutical Co., Ltd. Ligandzytotoxizitätswirkstoffkonjugat, herstellungsverfahren dafür und verwendungen davon
KR20170117473A (ko) * 2015-02-15 2017-10-23 지앙수 헨그루이 메디슨 컴퍼니 리미티드 리간드-세포독성 약물 접합체, 이의 제조 방법 및 이의 적용
CA3001847A1 (en) * 2015-10-22 2017-04-27 The Scripps Research Institute Cysteine reactive probes and uses thereof
GB201614152D0 (en) 2016-08-18 2016-10-05 Imp Innovations Ltd Assay
EP3570829A4 (de) 2017-01-18 2021-03-10 The Scripps Research Institute Fotoreaktive liganden und verwendungen davon
WO2018237334A1 (en) * 2017-06-23 2018-12-27 The Scripps Research Institute LYSINE-REACTIVE PROBES AND USES THEREOF

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011436A1 (en) * 1996-09-13 1998-03-19 Whitehead Institute For Biomedical Research Non-specific affinity enhancement to identify combinatorial library members
US6344330B1 (en) * 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6335155B1 (en) * 1998-06-26 2002-01-01 Sunesis Pharmaceuticals, Inc. Methods for rapidly identifying small organic molecule ligands for binding to biological target molecules

Also Published As

Publication number Publication date
AU2573102A (en) 2002-06-03
EP1441228B1 (de) 2006-06-28
DK1337853T3 (da) 2009-05-04
HK1063844A1 (en) 2005-01-14
ES2322796T3 (es) 2009-06-29
WO2002042773B1 (en) 2002-12-12
JP2004514891A (ja) 2004-05-20
IL155926A0 (en) 2003-12-23
DE60137356D1 (de) 2009-02-26
EP1337853A2 (de) 2003-08-27
WO2002042773A3 (en) 2002-11-14
NZ525861A (en) 2004-09-24
JP3836791B2 (ja) 2006-10-25
EP1337853B1 (de) 2009-01-07
CA2430234A1 (en) 2002-05-30
IL155926A (en) 2009-06-15
AU2002225731B2 (en) 2005-04-14
WO2002042773A2 (en) 2002-05-30
CA2430234C (en) 2008-02-12
JP2006113077A (ja) 2006-04-27
EP1441228A1 (de) 2004-07-28
ZA200303772B (en) 2004-05-17
MXPA03004435A (es) 2005-01-25

Similar Documents

Publication Publication Date Title
ATE420366T1 (de) ERWEITERTER ßTETHERINGß ANSATZ ZUM SCHNELLEN AUFFINDEN VON LIGANDEN
DE60226019D1 (de) Verfahren und system zum steuern von ausführbaren dateien mit geteilten bibliotheken
IL161016A (en) Polypeptides capable of ang-2 binding
DE60234425D1 (de) Verfahren zur optimaliserung von verkerhrsinformationsinhalt
IS5769A (is) Taugasæknir thættir
CY1111750T1 (el) Νευροτροφικοι παραγοντες
DE60142938D1 (de) Verfahren und Vorrichtung zum Identifizieren des Informationstyps, z.B. zum Identifizieren des Namensinhalts einer Musikdatei
NO20042843L (no) Mikrofluidinnretning og overflate dekorasjonsprosess for fast fase affinitets-bindings-analyser
ATE539156T1 (de) Vektoren zur gerichteten klonierung
DE60206573D1 (de) Verfahren zum Imprägnieren von Trägern
DE60045479D1 (de) Programmierverfahren zum Ermöglichen von Polymorphismus
ATE319996T1 (de) Verfahren zum auffinden eines heilmittels für krebs mit hilfe von interaktionsdomänen von p53 und mortalin
PT1118268E (pt) Metodo para a criopreservacao de esperma de peixe-zebra
DE29803336U1 (de) Zange zum Verpressen von Werkstücken
FR2853077B1 (fr) Procedes immunochromatographiques en phase solide
DE60113684D1 (de) Verfahren zum dispergieren von polyacrylamiden
DE1105508T1 (de) Verfahren zur reinigung von proteinen und biomolekül- oder proteinkomplexen
DE60332727D1 (de) Verwendung von fluor-nmr zum screening mit hohem durchsatz
DE60118296D1 (de) Gesimsbiegemaschine mit pneumatischem Steuersystem zum Schnellspannen von Gesimsbiegewerkzeugen
ATE370411T1 (de) Verfahren zum screening
CH695428A5 (de) Verfahren und Vorrichtung zur Entschärfung von Munition.
WO2002042777A3 (de) Modulierung der wechselwirkung zwischen evh1-domänen
FR2818747B1 (fr) Procede de criblage base sur l'interaction siah-numb
FI20010611A0 (fi) Menetelmä puutavaran kuivaamiseksi
DE60113643D1 (de) Verfahren zur Bindung von Nukleinsäuren an einen Träger

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337853

Country of ref document: EP

REN Ceased due to non-payment of the annual fee